3rd Quarter - Report

ARTHRITIS FOUNDATION for ARTHRITIS FOUNDATION

Firm
Client
Income
—
Expenses
$75,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

out-of-pocket costs, drug prices, utilization management, prior authorization, step therapy, clinical trial diversity, COVID-19 therapeutics, pharmacist scope of practice, telehealth extensions , association health plans, self-insurance protections, short-term limited duration insurance plans, Pharmacy Benefit Managers, -HR 830/S 1357,HELP Copays Act -HR 2630/ S. 652, Safe Step Act -S 1339, Pharmacy Benefit Manager Reform Act -HR 1770, the Equitable Community Access to Pharmacist Services Act -HR 824, the Telehealth Benefit Expansion for Workers Act -Accelerating Kid's Access to Care Act -Reducing Drug Prices for Seniors Act - Health Care Affordability Act

LobbyistCovered position, as disclosed
ALISA VIDULICH CASAVANT Policy Director
CHARLES HUSSER New Federal Affairs Manager
ANNA HYDE Vice President, Advocacy and Access

Contacted: Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 1770 (118th), H.R. 824 (118th), H.R. 2630 (118th), S. 652 (118th), H.R. 830 (118th)

Health Issues HCR

-HR 830 / S 1357, HELP Copays Act -HR 2630 / S 652, Safe Step Act -S 1339, Pharmacy Benefit Manager Reform Act -H.R. 1770, the Equitable Community Access to Pharmacist Services Act -HR 824, the Telehealth Benefit Expansion for Workers Act -Accelerating Kids Access to Care Act - S. 127 Pharmacy Benefit Manager Transparency Act of 2023 - S. 1339 Pharmacy Benefit Manager Reform Act - H.R. 4507 Transparency in Coverage Act of 2023 - H.R. 4822 Health Care Price Transparency Act of 2023 - H.R. 3561 PATIENT Act of 2023 -H.R. 5378 - The Lower Costs, More Transparency Act - H.R. 2761 SPARC Act, Specialty Physicians Advancing Rural Care (SPARC) Act - S.1701/H.R.3503 NIH Clinical Trial Diversity Act of 2023 - H.R. 1114 Long COVID RECOVERY NOW Act - S.2840 the Bipartisan Primary Care and Health Workforce Act - Reducing Drug Prices for Seniors Act - Improving Seniors Timely Access to Care Act - Health Care Affordability Act

LobbyistCovered position, as disclosed
ALISA VIDULICH CASAVANT New Policy Director
CHARLES HUSSER New Federal Affairs Manager
ANNA HYDE Vice President, Advocacy and Access

Contacted: HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5378 (118th), H.R. 3503 (118th), H.R. 3561 (118th), S. 2840 (118th), H.R. 1770 (118th), H.R. 830 (118th), H.R. 2630 (118th), H.R. 4507 (118th), H.R. 1114 (118th), S. 1701 (118th), H.R. 824 (118th), H.R. 4822 (118th), S. 127 (118th), S. 1339 (118th), H.R. 2761 (118th)

Budget/Appropriations BUD

FY24 Appropriations - PSLRP and CDRMP for Arthritis, NIH and CDC, improving osteoporosis care and awareness

LobbyistCovered position, as disclosed
ALISA VIDULICH CASAVANT New Policy Director
CHARLES HUSSER New Federal Affairs Manager
ANNA HYDE Vice President, Advocacy and Access

Contacted: Veterans Affairs, Dept of (VA); SENATE; HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.